MetaADEDB 2.0 @ LMMD
Triamcinolone
(GFNANZIMVAIWHM-OBYCQNJPSA-N)
Structure
SMILES
OCC(=O)[C@@]1(O)[C@H](O)C[C@@H]2[C@]1(C)C[C@H](O)[C@]1([C@H]2CCC2=CC(=O)C=C[C@]12C)F
Type(s)
Approved; Vet_approved
ATC code(s)
A01AC01; C05AA12; D07AB09; D07BB03; D07CB01; D07XB02; H02AB08; R01AD11; R03BA06; S01BA05; S02CA04
Molecular Formula:
C21H27FO6
Molecular Weight:
394.434
Log P:
0.6205
Hydrogen Bond Acceptor:
6
Hydrogen Bond Donor:
4
TPSA:
115.06
CAS Number(s):
124-94-7; 51855-44-8
Synonym(s)
1.
Triamcinolone
2.
Aristocort
3.
Volon
External Link(s)
MeSHD014221
PubChem Compound31307
BindingDB41132
ChEBI9667
CHEMBLCHEMBL1451
DrugBankDB00620
DrugCentral2725
IUPHAR/BPS Guide to PHARMACOLOGY2870
KEGGdr:D00385
Therapeutic Target DatabaseD03BLF
ZINC3882036
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 41
Canada Vigilance: 2		Canada Vigilance
OFFSIDES
US FAERS
2GlaucomaFAERS: 17SIDER
US FAERS
3Retinal Artery OcclusionFAERS: 17
Canada Vigilance: 1		12095826CTD
Canada Vigilance
US FAERS
4Deposit eyeFAERS: 16US FAERS
5PruritusFAERS: 16SIDER
US FAERS
6UrticariaFAERS: 14
Canada Vigilance: 1		Canada Vigilance
SIDER
US FAERS
7Ocular HypertensionFAERS: 12

View details

11272779
16764316
16888694
19403113
19939800
20089869
 		CTD
US FAERS
8FatigueFAERS: 11OFFSIDES
SIDER
US FAERS
9PainFAERS: 118916839
10414580
20133530		CTD
OFFSIDES
SIDER
US FAERS
10Anaphylactic shockFAERS: 10SIDER
US FAERS
11DizzinessFAERS: 10OFFSIDES
SIDER
US FAERS
12EndophthalmitisFAERS: 10
Canada Vigilance: 1		Canada Vigilance
SIDER
US FAERS
13NauseaFAERS: 10OFFSIDES
SIDER
US FAERS
14Product use in unapproved indicationFAERS: 10
Canada Vigilance: 1		Canada Vigilance
US FAERS
15CataractFAERS: 911272779
16888694		CTD
OFFSIDES
SIDER
US FAERS
16ErythemaFAERS: 9
Canada Vigilance: 1		Canada Vigilance
SIDER
US FAERS
17HeadacheFAERS: 9SIDER
US FAERS
18Retinal artery embolismFAERS: 9US FAERS
19Injection site atrophyFAERS: 8US FAERS
20LipoatrophyFAERS: 8US FAERS
21Optic AtrophyFAERS: 817955246CTD
US FAERS
22Scleral thinningFAERS: 8US FAERS
23Visual ImpairmentFAERS: 8US FAERS
24ArthralgiaFAERS: 7US FAERS
25BlindnessFAERS: 7SIDER
US FAERS
26Cytomegalovirus chorioretinitisFAERS: 7US FAERS
27Incorrect route of drug administrationFAERS: 7US FAERS
28Back PainFAERS: 6SIDER
US FAERS
29CellulitisFAERS: 6OFFSIDES
US FAERS
30EczemaFAERS: 6SIDER
US FAERS
31Injection site painFAERS: 6US FAERS
32Retinal DetachmentFAERS: 6
Canada Vigilance: 2		Canada Vigilance
US FAERS
33VomitingFAERS: 6SIDER
US FAERS
34AnxietyFAERS: 5OFFSIDES
SIDER
US FAERS
35ArthritisFAERS: 5OFFSIDES
US FAERS
36Gastrointestinal perforationFAERS: 5US FAERS
37MalaiseFAERS: 5SIDER
US FAERS
38PalpitationsFAERS: 5US FAERS
39Product compounding quality issueFAERS: 5US FAERS
40Product contaminationFAERS: 5US FAERS
41Product substitution issueFAERS: 5US FAERS
42Retinal DegenerationFAERS: 5US FAERS
43Steroid withdrawal syndromeFAERS: 5SIDER
US FAERS
44TinnitusFAERS: 5US FAERS
45Transmission of an infectious agent via a medicinal productFAERS: 5US FAERS
46Adverse eventFAERS: 4US FAERS
47Anaphylactoid ReactionFAERS: 4SIDER
US FAERS
48AsthmaFAERS: 4
Canada Vigilance: 1		Canada Vigilance
OFFSIDES
SIDER
US FAERS
49Cerebral InfarctionFAERS: 4US FAERS
50Chest PainFAERS: 4OFFSIDES
US FAERS
51Cutaneous nocardiosisFAERS: 4US FAERS
52EpistaxisFAERS: 4OFFSIDES
SIDER
US FAERS
53Eye painFAERS: 4OFFSIDES
SIDER
US FAERS
54Hypothalamic pituitary adrenal axis suppressionFAERS: 4US FAERS
55Injection Site ReactionFAERS: 4SIDER
US FAERS
56Metabolic alkalosisFAERS: 4US FAERS
57MyalgiaFAERS: 4SIDER
US FAERS
58Nasal discomfortFAERS: 4SIDER
US FAERS
59Retinal depositsFAERS: 4US FAERS
60AlopeciaFAERS: 3US FAERS
61AstheniaFAERS: 3OFFSIDES
SIDER
US FAERS
62ChillsFAERS: 3US FAERS
63CyanosisFAERS: 3
Canada Vigilance: 1		Canada Vigilance
US FAERS
64Drug dispensing errorFAERS: 3US FAERS
65Dry skinFAERS: 3SIDER
US FAERS
66EmbolismFAERS: 3SIDER
US FAERS
67Extremity necrosisFAERS: 3US FAERS
68Eye InfectionFAERS: 3US FAERS
69FlushingFAERS: 3US FAERS
70HepatomegalyFAERS: 3SIDER
US FAERS
71Injection site plaqueFAERS: 3US FAERS
72Intestinal PerforationFAERS: 3US FAERS
73Joint InstabilityFAERS: 3US FAERS
74Lichen PlanusFAERS: 3US FAERS
75Lichen striatusFAERS: 3US FAERS
76Medication ErrorFAERS: 3US FAERS
77Myocardial InfarctionFAERS: 3SIDER
US FAERS
78NecrosisFAERS: 315689233CTD
US FAERS
79No adverse eventFAERS: 3US FAERS
80Non-infectious endophthalmitisFAERS: 3US FAERS
81OverdoseFAERS: 3US FAERS
82Product contamination microbialFAERS: 3US FAERS
83Product quality issueFAERS: 3OFFSIDES
US FAERS
84Retinal Vascular DisorderFAERS: 3US FAERS
85ScotomaFAERS: 3US FAERS
86Skin UlcerFAERS: 3US FAERS
87Skin lesionFAERS: 3OFFSIDES
US FAERS
88SwellingFAERS: 3US FAERS
89Toxic anterior segment syndromeFAERS: 3US FAERS
90Transmission of an infectious agent via productFAERS: 3US FAERS
91Visual acuity tests abnormalFAERS: 3US FAERS
92Vitreous floatersFAERS: 3SIDER
US FAERS
93Weight decreasedFAERS: 3SIDER
US FAERS
94treatment failureFAERS: 3US FAERS
95Abdominal PainFAERS: 2OFFSIDES
SIDER
US FAERS
96AbscessFAERS: 2SIDER
US FAERS
97Accidental exposure to productFAERS: 2US FAERS
98AcneFAERS: 2
Canada Vigilance: 1		Canada Vigilance
SIDER
US FAERS
99Altered state of consciousnessFAERS: 2US FAERS
100AmnesiaFAERS: 2US FAERS
101AmputationFAERS: 2US FAERS
102Blood glucose increasedFAERS: 2US FAERS
103Burning sensationFAERS: 2US FAERS
104Cerebrovascular accidentFAERS: 2SIDER
US FAERS
105Chest discomfortFAERS: 2US FAERS
106Corneal lesionFAERS: 2US FAERS
107DeafnessFAERS: 2US FAERS
108Depressed moodFAERS: 2OFFSIDES
US FAERS
109Diabetes MellitusFAERS: 2
Canada Vigilance: 1		Canada Vigilance
SIDER
US FAERS
110DiscomfortFAERS: 2SIDER
US FAERS
111Drug DependenceFAERS: 2SIDER
US FAERS
112Drug ineffective for unapproved indicationFAERS: 2
Canada Vigilance: 1		Canada Vigilance
US FAERS
113Drug level increasedFAERS: 2US FAERS
114Drug prescribing errorFAERS: 2US FAERS
115Eye irritationFAERS: 2SIDER
US FAERS
116Eyeball ruptureFAERS: 2US FAERS
117Facial PainFAERS: 2US FAERS
118Feeling abnormalFAERS: 2SIDER
US FAERS
119FibrosisFAERS: 2US FAERS
120Food AllergyFAERS: 2US FAERS
121Gastric ulcerFAERS: 2US FAERS
122General physical health deteriorationFAERS: 2US FAERS
123Hormone level abnormalFAERS: 2US FAERS
124HypertrichosisFAERS: 2SIDER
US FAERS
125HypotensionFAERS: 29052326CTD
SIDER
US FAERS
126HypoxiaFAERS: 2US FAERS
127Incorrect dose administeredFAERS: 2US FAERS
128InfectionFAERS: 23536491CTD
OFFSIDES
SIDER
US FAERS
129Injection site abscessFAERS: 2US FAERS
130Injection site necrosisFAERS: 2US FAERS
131IridoceleFAERS: 2US FAERS
132Joint Range of Motion DecreasedFAERS: 2US FAERS
133Macular degenerationFAERS: 2US FAERS
134MediastinitisFAERS: 2US FAERS
135Memory impairmentFAERS: 2US FAERS
136MetamorphopsiaFAERS: 2US FAERS
137OsteoporosisFAERS: 2SIDER
US FAERS
138PallorFAERS: 2US FAERS
139PanniculitisFAERS: 2US FAERS
140ParanoiaFAERS: 2US FAERS
141PhotophobiaFAERS: 2US FAERS
142Post procedural complicationFAERS: 2OFFSIDES
US FAERS
143Product use issueFAERS: 2US FAERS
144PseudoendophthalmitisFAERS: 2US FAERS
145Psoas AbscessFAERS: 2US FAERS
146PsoriasisFAERS: 2OFFSIDES
US FAERS
147PurpuraFAERS: 2SIDER
US FAERS
148Retinal pigment epithelial tearFAERS: 2US FAERS
149Retinal thickeningFAERS: 2US FAERS
150RhinitisFAERS: 2OFFSIDES
SIDER
US FAERS
151Soft tissue atrophyFAERS: 2US FAERS
152SynovitisFAERS: 2OFFSIDES
US FAERS
153ThrombosisFAERS: 2US FAERS
154TremorFAERS: 2US FAERS
155TuberculosisFAERS: 2SIDER
US FAERS
156Upper-airway cough syndromeFAERS: 2US FAERS
157VasculitisFAERS: 2SIDER
US FAERS
158VertigoFAERS: 2SIDER
US FAERS
159WheezingFAERS: 2SIDER
US FAERS
160Wrong technique in drug usage processFAERS: 2OFFSIDES
US FAERS
161muscle injuryFAERS: 2OFFSIDES
US FAERS
162AcanthosisFAERS: 1US FAERS
163AcarodermatitisFAERS: 1US FAERS
164Accidental exposureFAERS: 1US FAERS
165Accidental overdoseFAERS: 1OFFSIDES
US FAERS
166Activities of daily living impairedFAERS: 1US FAERS
167Administration site reactionFAERS: 1US FAERS
168AgitationFAERS: 1US FAERS
169AngerFAERS: 1US FAERS
170AppendicitisFAERS: 1US FAERS
171Application site drynessFAERS: 1US FAERS
172ArachnoiditisFAERS: 1SIDER
US FAERS
173AscitesFAERS: 1US FAERS
174Blood Corticotrophin DecreasedFAERS: 1US FAERS
175Blood glucose abnormalFAERS: 1US FAERS
176Bone painFAERS: 1
Canada Vigilance: 1		Canada Vigilance
US FAERS
177Breast infectionFAERS: 1US FAERS
178BronchitisFAERS: 1OFFSIDES
SIDER
US FAERS
179CalcinosisFAERS: 1OFFSIDES
SIDER
US FAERS
180CandidiasisFAERS: 1US FAERS
181Cardiac ArrestFAERS: 1SIDER
US FAERS
182Cardiac stress test abnormalFAERS: 1US FAERS
183CardiomegalyFAERS: 1SIDER
US FAERS
184Choking sensationFAERS: 1OFFSIDES
US FAERS
185ChromoblastomycosisFAERS: 1US FAERS
186Chronic sinusitisFAERS: 1OFFSIDES
US FAERS
187Cold sweatFAERS: 1US FAERS
188Conjunctival ulcerFAERS: 1US FAERS
189Dermal absorption impairedFAERS: 1US FAERS
190Dermatitis acneiformFAERS: 1SIDER
US FAERS
191Detachment of retinal pigment epitheliumFAERS: 1SIDER
US FAERS
192Device malfunctionFAERS: 1US FAERS
193DisabilityFAERS: 1US FAERS
194DisorientationFAERS: 1US FAERS
195Drug administered at inappropriate siteFAERS: 1US FAERS
196Drug administration errorFAERS: 1US FAERS
197Drug effect incompleteFAERS: 1US FAERS
198Drug resistanceFAERS: 1US FAERS
199Dystrophic calcificationFAERS: 1US FAERS
200Ear discomfortFAERS: 1US FAERS
201Emotional disorderFAERS: 1US FAERS
202Emotional distressFAERS: 1OFFSIDES
US FAERS
203Erythema MultiformeFAERS: 1US FAERS
204Euphoric moodFAERS: 1SIDER
US FAERS
205Eye excisionFAERS: 1US FAERS
206Eye infection syphiliticFAERS: 1US FAERS
207FasciitisFAERS: 1US FAERS
208Foreign body traumaFAERS: 1US FAERS
209Gastrointestinal ulcerFAERS: 1US FAERS
210HungerFAERS: 1US FAERS
211Hypereosinophilic syndromeFAERS: 1US FAERS
212HyperkeratosisFAERS: 1US FAERS
213HypersensitivityFAERS: 1
Canada Vigilance: 2		Canada Vigilance
SIDER
US FAERS
214HypopyonFAERS: 1SIDER
US FAERS
215HyporeflexiaFAERS: 1US FAERS
216HypothyroidismFAERS: 1US FAERS
217Immediate post-injection reactionFAERS: 1US FAERS
218ImmobileFAERS: 1US FAERS
219Inappropriate schedule of drug administrationFAERS: 1US FAERS
220Incorrect route of product administrationFAERS: 1
Canada Vigilance: 1		Canada Vigilance
US FAERS
221IndurationFAERS: 1US FAERS
222InflammationFAERS: 1SIDER
US FAERS
223Injected limb mobility decreasedFAERS: 1US FAERS
224Injection site extravasationFAERS: 1US FAERS
225Injection site fibrosisFAERS: 1US FAERS
226Injection site massFAERS: 1US FAERS
227Injection site scarFAERS: 1US FAERS
228Intercepted drug dispensing errorFAERS: 1US FAERS
229Joint injuryFAERS: 1OFFSIDES
US FAERS
230Lens dislocationFAERS: 1US FAERS
231LethargyFAERS: 1SIDER
US FAERS
232LeukocytosisFAERS: 1SIDER
US FAERS
233Ligament ruptureFAERS: 1OFFSIDES
US FAERS
234Lip swellingFAERS: 1US FAERS
235Liquid product physical issueFAERS: 1US FAERS
236Livedo ReticularisFAERS: 1
Canada Vigilance: 1		Canada Vigilance
US FAERS
237Macular detachmentFAERS: 1US FAERS
238Macular fibrosisFAERS: 1US FAERS
239Macular ruptureFAERS: 1US FAERS
240MastitisFAERS: 1US FAERS
241Maternal exposure during pregnancyFAERS: 1US FAERS
242Melanoma recurrentFAERS: 1US FAERS
243Mental impairmentFAERS: 1US FAERS
244Mental status changesFAERS: 1OFFSIDES
US FAERS
245Metastases to muscleFAERS: 1US FAERS
246Mucosal erosionFAERS: 1US FAERS
247Musculoskeletal PainFAERS: 1OFFSIDES
US FAERS
248Myasthenia GravisFAERS: 1US FAERS
249Mycoplasma test positiveFAERS: 1US FAERS
250Nerve injuryFAERS: 1SIDER
US FAERS
251Night sweatsFAERS: 1US FAERS
252NocturiaFAERS: 1US FAERS
253OnychoclasisFAERS: 1US FAERS
254Optic NeuropathyFAERS: 1US FAERS
255Optic nerve cuppingFAERS: 1US FAERS
256OsteolysisFAERS: 1OFFSIDES
US FAERS
257OsteopeniaFAERS: 1US FAERS
258PanophthalmitisFAERS: 1SIDER
US FAERS
259PapuleFAERS: 1
Canada Vigilance: 1		Canada Vigilance
US FAERS
260Paranasal sinus discomfortFAERS: 1US FAERS
261ParaparesisFAERS: 1SIDER
US FAERS
262Paraspinal abscessFAERS: 1US FAERS
263Partner stressFAERS: 1US FAERS
264Peripheral swellingFAERS: 1US FAERS
265PeritonitisFAERS: 1US FAERS
266PharyngitisFAERS: 1SIDER
US FAERS
267Postoperative infectionFAERS: 1US FAERS
268PregnancyFAERS: 1US FAERS
269Procedural complicationFAERS: 1US FAERS
270Product administration errorFAERS: 1
Canada Vigilance: 2		Canada Vigilance
US FAERS
271Product intoleranceFAERS: 1US FAERS
272Product label issueFAERS: 1US FAERS
273Product packaging quantity issueFAERS: 1US FAERS
274Product physical issueFAERS: 1US FAERS
275Product preparation errorFAERS: 1US FAERS
276Psychiatric symptomFAERS: 1US FAERS
277Rash erythematousFAERS: 1US FAERS
278Respiratory arrestFAERS: 1US FAERS
279Retinal VasculitisFAERS: 1US FAERS
280Retinal Vein OcclusionFAERS: 1US FAERS
281Retinal infarctionFAERS: 1US FAERS
282Retinal scarFAERS: 1US FAERS
283Retinal vascular occlusionFAERS: 1US FAERS
284RetinitisFAERS: 1US FAERS
285ScleritisFAERS: 1US FAERS
286Secretion dischargeFAERS: 1US FAERS
287SepsisFAERS: 1US FAERS
288Sinus headacheFAERS: 1US FAERS
289SinusitisFAERS: 1SIDER
US FAERS
290Skin PapillomaFAERS: 1US FAERS
291Skin dystrophyFAERS: 1US FAERS
292Skin hypertrophyFAERS: 1US FAERS
293Skin irritationFAERS: 1US FAERS
294Skin lacerationFAERS: 1US FAERS
295Skin necrosisFAERS: 1US FAERS
296Spinal artery embolismFAERS: 1US FAERS
297Spinal cord abscessFAERS: 1US FAERS
298Staphylococcal abscessFAERS: 1US FAERS
299Subcutaneous AbscessFAERS: 1US FAERS
300Suppressed lactationFAERS: 1US FAERS
301Systemic Inflammatory Response SyndromeFAERS: 1US FAERS
302Therapy cessationFAERS: 1US FAERS
303Throat irritationFAERS: 1US FAERS
304Unevaluable eventFAERS: 1US FAERS
305UveitisFAERS: 111272779
12095826
16888694		CTD
US FAERS
306VitrectomyFAERS: 1US FAERS
307White blood cell count abnormalFAERS: 1US FAERS
308Wrong drug administeredFAERS: 1US FAERS
309Wrong technique in product usage processFAERS: 1US FAERS
310Abdominal discomfortOFFSIDES
SIDER
311Abnormal visionOFFSIDES
312AbuseOFFSIDES
313AcheSIDER
314Acid refluxOFFSIDES
315Acute Coronary SyndromeSIDER
316Acute bronchitisOFFSIDES
317Acute myocardial infarctionOFFSIDES
318Adrenal Cortex Diseases7788158CTD
319Aldolase increasedOFFSIDES
320AngioedemaSIDER
321AnhedoniaOFFSIDES
322Ankle FractureOFFSIDES
323Anorexia8665051CTD
OFFSIDES
SIDER
324Anterior chamber flareSIDER
325Anterior chamber inflammationOFFSIDES
326Anticoagulation drug level below therapeuticOFFSIDES
327Antinuclear antibody increasedOFFSIDES
328Aortic AneurysmOFFSIDES
329Aortic valve sclerosisOFFSIDES
330AphoniaOFFSIDES
331Application site reactionSIDER
332ArthropathyOFFSIDES
SIDER
333ArthroscopyOFFSIDES
334Aseptic necrosisSIDER
335AspergillosisOFFSIDES
336AtelectasisOFFSIDES
337AuraOFFSIDES
338Autoimmune hepatitisOFFSIDES
339Basal cell carcinomaOFFSIDES
340Bipolar Disorder8916839CTD
341Bipolar I disorderOFFSIDES
342Bladder dysfunctionSIDER
343Bladder painSIDER
344Blood 1,25-dihydroxycholecalciferol decreasedOFFSIDES
345Blood GlucoseOFFSIDES
346Blood alkaline phosphatase increasedOFFSIDES
347Blood cholesterol increasedSIDER
348Blood cholesterolOFFSIDES
349Blood cortisol decreasedSIDER
350Blood count abnormalOFFSIDES
351Blood creatine phosphokinase increasedOFFSIDES
352Blood creatinine increasedOFFSIDES
353Blood potassium decreasedSIDER
354Blood pressure inadequately controlledOFFSIDES
355Blood thyroid stimulating hormoneOFFSIDES
356Blood triglycerides increasedOFFSIDES
SIDER
357Blood urine presentOFFSIDES
358Bone density decreasedOFFSIDES
359Bone fistulaOFFSIDES
360Bone lesionOFFSIDES
361BradycardiaOFFSIDES
SIDER
362Breast FeedingSIDER
363BunionOFFSIDES
364BursitisOFFSIDES
SIDER
365Calcific deposits removalOFFSIDES
366Carbohydrate tolerance decreasedSIDER
367Cardioactive drug level above therapeuticOFFSIDES
368CausalgiaOFFSIDES
369Cerebral atrophyOFFSIDES
370Cerebrovascular accident prophylaxisOFFSIDES
371Chemotherapeutic drug level increasedOFFSIDES
372Choroid Diseases12095826CTD
373ChromaturiaOFFSIDES
374Circumstance or information capable of leading to medication errorOFFSIDES
375CirrhosisOFFSIDES
376Cleft Palate2998748CTD
SIDER
377ColitisOFFSIDES
378ConjunctivitisSIDER
379Contralateral breast cancerOFFSIDES
380Corneal dystrophyOFFSIDES
381CryotherapyOFFSIDES
382Culture positiveOFFSIDES
383Cushing Syndrome7788158CTD
384CystitisSIDER
385DebridementOFFSIDES
386DemyelinationOFFSIDES
387Dental abscessOFFSIDES
388DependenceOFFSIDES
389Depressed Level of ConsciousnessOFFSIDES
390DermatitisSIDER
391DermatomyositisOFFSIDES
392Device material opacificationCanada Vigilance: 1Canada Vigilance
393DiabetesOFFSIDES
394Diabetic Retinopathy17932855
20408067		CTD
395DiabeticSIDER
396DiarrheaOFFSIDES
397DiplegiaSIDER
398DiplopiaOFFSIDES
399Disseminated Intravascular CoagulationOFFSIDES
400DiverticulosisOFFSIDES
401DrowsinessOFFSIDES
402Drug level below therapeuticOFFSIDES
403Drug withdrawal headacheOFFSIDES
404Drug withdrawal syndromeSIDER
405Dry scalpSIDER
406DysgeusiaCanada Vigilance: 1Canada Vigilance
OFFSIDES
SIDER
407DyslexiaOFFSIDES
408DyslogiaOFFSIDES
409DyspepsiaOFFSIDES
SIDER
410DysphemiaOFFSIDES
411DysphoniaSIDER
412DystoniaOFFSIDES
413EcchymosisSIDER
414Endodontic procedureOFFSIDES
415EnuresisOFFSIDES
416Enzyme abnormalityOFFSIDES
417EpicondylitisOFFSIDES
418Epinephrine increasedOFFSIDES
419Erectile dysfunctionOFFSIDES
420Essential HypertensionOFFSIDES
421ExcoriationSIDER
422ExophthalmosSIDER
423Fatty LiverOFFSIDES
424Febrile NeutropeniaOFFSIDES
425Feeling ColdOFFSIDES
426FibromyalgiaOFFSIDES
427FlatulenceOFFSIDES
428FolliculitisSIDER
429Foreign body sensation in eyesSIDER
430FormicationOFFSIDES
431FractureSIDER
432GamblingOFFSIDES
433GanglioneuroblastomaOFFSIDES
434Gastric BypassOFFSIDES
435Gastrointestinal PainSIDER
436GlycosuriaSIDER
437GoutOFFSIDES
438GranulomaSIDER
439Grip strengthOFFSIDES
440Growth retardationSIDER
441HepatitisOFFSIDES
442HirsutismSIDER
443HoarsenessSIDER
444HydrocephalusSIDER
445Hypertensive emergencyOFFSIDES
446Hypertrophic CardiomyopathySIDER
447HypokinesiaCanada Vigilance: 1Canada Vigilance
SIDER
448Hyponatremia20111051CTD
449HypophagiaOFFSIDES
450Impaired driving abilityOFFSIDES
451Increased insulin requirementSIDER
452Increased tendency to bruiseSIDER
453InfluenzaSIDER
454Infusion site mobility decreasedOFFSIDES
455Injection site infectionOFFSIDES
456Injection site irritationSIDER
457Intentional drug misuseOFFSIDES
458Intervertebral Disc DegenerationOFFSIDES
459Intestinal ObstructionOFFSIDES
460Itch burningSIDER
461LaparotomyOFFSIDES
462LeukodermaSIDER
463Leukopenia neonatalOFFSIDES
464Life expectancy shortenedOFFSIDES
465Limb injuryOFFSIDES
466Lipomatosis10414580CTD
467Low Back Pain9052326CTD
468Lupus ErythematosusSIDER
469Mass excisionOFFSIDES
470MeningitisSIDER
471Meniscus removalOFFSIDES
472MetaplasiaOFFSIDES
473MiliariaSIDER
474Monoclonal immunoglobulin presentOFFSIDES
475MonoplegiaSIDER
476Mood swingsSIDER
477Muscle Weakness7788158
8413452		CTD
OFFSIDES
478Muscle strainOFFSIDES
479Muscular Atrophy

View details

3912638
7349575
8665051
8937196
 		CTD
480Musculoskeletal discomfortSIDER
481Musculoskeletal stiffnessOFFSIDES
482Myocardial ruptureSIDER
483Myoclonus9052326CTD
484MyopathyCanada Vigilance: 1Canada Vigilance
SIDER
485MyopiaOFFSIDES
486Nasal burningSIDER
487NasopharyngitisSIDER
488Nerve BlockOFFSIDES
489NeuralgiaOFFSIDES
490NeuritisSIDER
491NeuropathySIDER
492Nitrogen balance negativeSIDER
493NoduleOFFSIDES
494OnychalgiaOFFSIDES
495Open reduction of fractureOFFSIDES
496OphthalmoplegiaOFFSIDES
497Optic NeuritisSIDER
498Optic disc vascular disorderSIDER
499Oral candidiasisSIDER
500Oral infectionOFFSIDES
501Oropharyngeal discomfortSIDER
502Oropharyngeal painOFFSIDES
SIDER
503Orthostatic hypertensionOFFSIDES
504OsteomyelitisOFFSIDES
505OsteosclerosisOFFSIDES
506Otitis MediaSIDER
507OverweightOFFSIDES
508PancreatitisSIDER
509Panic DisorderOFFSIDES
510ParaplegiaSIDER
511Peptic UlcerSIDER
512Pericardial effusionOFFSIDES
513Pericarditis20133530CTD
514Perirectal abscessOFFSIDES
515Personality ChangeSIDER
516PetechiaeSIDER
517Pharyngolaryngeal PainSIDER
518Polymyalgia RheumaticaOFFSIDES
519PolymyositisOFFSIDES
520Polysubstance abuseOFFSIDES
521Portal HypertensionOFFSIDES
522Portal Vein ThrombosisOFFSIDES
523Posterior subcapsular cataractSIDER
524Postmenopausal bleedingOFFSIDES
525Potassium DeficiencySIDER
526Primary sequestrumOFFSIDES
527Productive CoughOFFSIDES
528PseudocystOFFSIDES
529Pulmonary HypertensionOFFSIDES
530Pulmonary congestionOFFSIDES
SIDER
531Purulent dischargeOFFSIDES
532PyodermaSIDER
533QuadriplegiaSIDER
534Radicular painOFFSIDES
535Rectal polypOFFSIDES
536Refusal of treatment by relativeOFFSIDES
537Renal Artery StenosisOFFSIDES
538Respiratory tract congestionSIDER
539Retinal pigment epitheliopathyCanada Vigilance: 2Canada Vigilance
540Retrobulbar Hemorrhage12095826CTD
541Retrograde portal vein flowOFFSIDES
542Rhinitis perennialSIDER
543RosaceaSIDER
544Salpingo-oophorectomyOFFSIDES
545SarcoidosisOFFSIDES
546Septic ShockOFFSIDES
547SeptoplastyOFFSIDES
548ShockSIDER
549Sick Sinus SyndromeOFFSIDES
550Skeletal injuryOFFSIDES
551Skin neoplasm excisionOFFSIDES
552Sleep TalkingOFFSIDES
553SneezingSIDER
554Spinal Stenosis10414580CTD
555Spinal column stenosisOFFSIDES
556Splenic InfectionOFFSIDES
557Stomatocytes presentOFFSIDES
558Sudden Cardiac DeathOFFSIDES
559SyncopeSIDER
560Synovial CystOFFSIDES
561TachycardiaSIDER
562TalipesOFFSIDES
563Tardive DyskinesiaOFFSIDES
564Temperature intoleranceOFFSIDES
565Temporomandibular ankylosis15689233CTD
566TendinitisOFFSIDES
567TenosynovitisOFFSIDES
SIDER
568Therapy non-responderCanada Vigilance: 1Canada Vigilance
569ThromboembolismSIDER
570ThrombophlebitisSIDER
571Tooth ExtractionOFFSIDES
572Tooth InfectionOFFSIDES
573Tooth LossOFFSIDES
574ToothacheSIDER
575Transfusion ReactionOFFSIDES
576TraumaSIDER
577Troponin increasedOFFSIDES
578UlcerOFFSIDES
SIDER
579Urinary tract infectionSIDER
580Varicose vein operationOFFSIDES
581Vascular purpuraSIDER
582Vertebrobasilar InsufficiencyOFFSIDES
583Violence-related symptomOFFSIDES
584Vitreous DetachmentSIDER
585Weight GainOFFSIDES
586furuncleOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120235

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.